Discovery of New Quinazoline-Based Anticancer Agents as VEGFR-2 Inhibitors and Apoptosis Inducers
作者:M. F. Ahmed、A. S. Khalifa、E. M Eed
DOI:10.1134/s1068162022040033
日期:2022.8
Abstract Novel quinazoline compounds have been designed and synthesized aiming to discover new anticancer agents. Additional study was carried out on the most powerful derivatives, (Xb). A cell cycle research indicated that (Xb) mostly stops the cell cycle in the G2/M phase. The Annexin V-FITC apoptosis assay revealed that (Xb) increased apoptosis when compared with the control. It also demonstrated
摘要 已经设计和合成了新的喹唑啉化合物,旨在发现新的抗癌剂。对最强大的衍生物( Xb )进行了额外的研究。一项细胞周期研究表明,( Xb ) 主要在 G2/M 期停止细胞周期。膜联蛋白 V-FITC 细胞凋亡测定显示,与对照相比,( Xb ) 增加了细胞凋亡。它还证明了抗凋亡 Bcl-2 蛋白表达降低和 BAX 和半胱天冬酶 3 表达水平增加。